Russell Flannery, Forbes Staff

Author's posts

The Doctors Are In: Cancer Experts Try To Boost Ailing U.S.-China Relations

The rise of Joe Biden as U.S. president has stirred hopes for a bigger push for cancer cures from the U.S. government side

Biden’s Next Big Push With China May Be In Healthcare And The Fight Against Cancer

The death of son Beau Biden from cancer spurred an effort by then U.S. Vice President Joe Biden to organize a “National Cancer Moonshot Initiative” to support research to “end cancer as we know it.”

China Adds New Billionaire Couple From Medical Industry

China is home to the world’s largest number of billionaires after the United States

“AI 2041” Co-Author Kai-Fu Lee Talks About AI’s Sweeping Future And How He Invests In It

Healthcare, manufacturing, transportation facing change

Expanding International Clinical Trials For Cancer Saves Lives. Why Not Act Faster?

More people around the world will die from cancer than from Covid-19 this year

Adrian Cheng Moves Deeper Into Healthcare Industry With Artisan Merger Of Prenetics At $1.2 Bln Valuation

Follows recent EC Healthcare investment

China’s Simcere Pharmaceutical Advances At Home After Exit From NYSE

“Learning and Adapting” Fuel Progress, Billionaire Chairman Ren Jinsheng Says

U.S.-China Cancer Collaboration Could Open Door For New “Ping-Pong Diplomacy”: Kevin Rudd

A joint effort by the U.S. and China to fight cancer could represent a latter-day equivalent of the exchange of table tennis players between the two countries that led to a thaw in relations in the 1970s

Tonight! Novartis, Roche, BeiGene, Others Discuss Global Fight Against Cancer In Covid Era

Cancer patients are more vulnerable to contracting Covid-19, and have more than double the death rate from Covid-19 compared with patients without cancer

FDA, MSK, Novartis, Kevin Rudd To Discuss Int’l Collaboration To Fight Cancer On Aug. 27

Free event will be held online